Showing 341 - 360 results of 870 for search '"prostate"', query time: 0.05s Refine Results
  1. 341
  2. 342
  3. 343
  4. 344
  5. 345

    Immunohistochemical Detection and Localization of Somatostatin Receptor Subtypes in Prostate Tissue from Patients with Bladder Outlet Obstruction by Rodolfo Montironi, Liang Cheng, Roberta Mazzucchelli, Doriana Morichetti, Daniela Stramazzotti, Alfredo Santinelli, Gianluca Moroncini, Andrea B. Galosi, Giovanni Muzzonigro, Giancarlo Comeri, Jon Lovisolo, Sergio Cosciani-Cunico, Aldo V. Bono

    Published 2008-01-01
    “…Background and Aim of the Study: Scant information on the cellular distribution of the five somatostatin receptor (SSTR) subtypes in the normal prostate and in neoplasms of the prostate has been reported in very few studies in which techniques, such as in situ hybridization histochemistry, autoradiography, and more recently immunohistochemistry, have been applied. …”
    Get full text
    Article
  6. 346

    The Practice of Scottish Urologists in the Assessment and Management of Fracture Risk in the Ageing Male being Treated for Prostate Cancer by Wee Sing Ngu, Derek J. Byrne

    Published 2007-01-01
    “…The aim of this study was to ascertain the practice of urologists in Scotland in the assessment and prevention of fracture risk in males starting castration-type therapy for prostate cancer. A questionnaire survey was sent to all practicing consultant urologists in Scotland. …”
    Get full text
    Article
  7. 347
  8. 348
  9. 349

    Management of perianesthesia in benign prostate hyperplasia patients with transvesica prostatectomy and uncontrolled hypertension: A case report by Suandika Made, Puspita Valentina Intan Ayu, Utami Tin

    Published 2025-01-01
    “…The prevalence of Benign Prostate Hyperplasia (BPH) increases at the age of 40 years to 90 years. …”
    Get full text
    Article
  10. 350
  11. 351

    Attitudes and adherence to changes in nutrition and physical activity following surgery for prostate cancer: a qualitative study by Richard M Martin, Raj Persad, J Athene Lane, Ellie Shingler, Luke A Robles, Edward Rowe, Anthony Koupparis, Amit Bahl, Constance Shiridzinomwa, Lucy McGeagh

    Published 2022-06-01
    “…We aimed to explore these factors in men following prostatectomy for prostate cancer (PCa).Design, setting and participants A qualitative study using semistructured interviews with men, who made changes to their diet and/or PA as part of a factorial randomised controlled trial conducted at a single hospital in South West England. …”
    Get full text
    Article
  12. 352
  13. 353

    ABA enhances the apoptotic effect of docetaxel in the multidrug-resistant DU145 prostate cancer cell line by Şumnulu Deniz, Doğanlar Zeynep Banu

    Published 2024-01-01
    “…This study aimed to induce drug resistance in DU145 prostate cancer cells by exposing them to docetaxel and mitoxantrone, and to examine the effects of combining docetaxel and abscisic acid (ABA). …”
    Get full text
    Article
  14. 354

    Effectiveness of GnRH Antagonists and Agonists in Patients with Hormone-Sensitive Prostate Cancer: A Retrospective Study by Zhenghao Liu, Chunguang Yang, Xing Zeng, Chunjin Ke, Jihua Tian, Zhihua Wang, Zhiquan Hu

    Published 2022-01-01
    “…To assess the effectiveness of gonadotropin-releasing hormone (GnRH) antagonists and agonists in the treatment of patients with hormone-sensitive prostate cancer (HSPC), thus providing valid data support for their clinical treatment. …”
    Get full text
    Article
  15. 355
  16. 356

    Life after prostate cancer diagnosis: protocol for a UK-wide patient-reported outcomes study by David H Brewster, Victoria Cairnduff, Eila Watson, Amy Downing, Adam W Glaser, Penny Wright, William Cross, Conan Donnelly, Anna Gavin, Carol Rivas, Richard Wagland, Peter Selby, Luke Hounsome, Therese Kearney, Rebecca Mottram, Majorie Allen, Oonagh McSorley, Hugh Butcher, Paul Kind, James W H Catto, Dyfed Huws, Emma McNair, Lauren Matheson, Johana Nayoan, Mike Horton, Jessica Corner, Julia Verne

    Published 2016-12-01
    “…The Life After Prostate Cancer Diagnosis (LAPCD) study is a UK-wide patient-reported outcomes study which will generate information to improve the health and well-being of men with prostate cancer.Methods and analysis Postal surveys will be sent to prostate cancer survivors (18–42 months postdiagnosis) in all 4 UK countries (n=∼70 000). …”
    Get full text
    Article
  17. 357
  18. 358
  19. 359
  20. 360